Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

OptimizeRx Corporation - Common Stock (NQ:OPRX)

12.97 -1.02 (-7.29%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about OptimizeRx Corporation - Common Stock

< Previous 1 2 3 Next >
OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community’ Outreach Effort
Empowering healthcare providers to remove barriers to care 
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx to Participate in Upcoming Investor Conferences
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business Update
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx to Participate at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Reports Third Quarter 2023 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Announces Completion of Medicx Acquisition and Sets Third Quarter 2023 Conference Call for November 6, 2023, at 8:30 a.m. ET
Executive Leadership expands with Steve Silvestro being promoted to President, and Theresa Greco assuming the role of Chief Commercial Officer 
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Announces Agreement to Acquire Medicx Health for $95 million to Expand its Omnichannel Reach to Consumers
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Unveils a Significant Enhancement to its Omni-channel Healthcare Engagement Platform
The New AI-Directed Capability Unites Point-of-Care and Traditional Digital Medias to Provide a Comprehensive Solution for Pharmaceutical Marketing 
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Expands AI Powered Omnichannel Platform
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Reports Second Quarter 2023 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Sets Second Quarter 2023 Conference Call for August 14, 2023 at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx’s CEO Provides 2023 Midyear Strategic Update
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx’s Karina Castagna Named One of the 2023 PM360 ELITE 100
Castagna was recognized as a Digital Crusader for her ongoing and leading-edge work in digital access to therapies for patients 
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx to Participate in Upcoming Investor Conferences
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Reports First Quarter 2023 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
Surveyed Physicians Spell Out Preferences for Data-driven, Omnichannel Content That Delivers Clinical Relevance
Physicians report that they are encountering brand information across multiple digital and in-person channels, yet still lack key information on patient eligibility, affordability, and access 
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Sets First Quarter 2023 Conference Call for May 10, 2023at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Releases 2023 Environmental, Social and Governance (ESG) Report
From OptimizeRx Corporation
Via GlobeNewswire
Financial Times Ranks OptimizeRx Amongst The Americas’ Fastest Growing Companies for the Fourth Consecutive Year
– AI driven RWD deals grow from 6 completed in 2022 to several dozen in pipeline today, representing the rapid adoption of OptimizeRx’s health technology enablement platform services 
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Authorizes $15 Million Share Repurchase Program
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Announces Multi-Year Agreement with Top Hub Services Provider to Accelerate Access for Patients
Deal will enable high-growth patient services company to streamline and enhance its services with OptimizeRx’s technology solutions 
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Reports Fourth Quarter and Full Year 2022 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Sets Fourth Quarter & Fiscal Year 2022 Conference Call for March 8, 2023 at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx’s Karina Castagna Named to MM+M’s 40 Under 40 List of the Medical Marketing Industry’s Brightest Young Stars
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx CEO Issues Open Letter to Shareholders Ahead of Presentation at J.P. Morgan Healthcare Conference
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx to Participate in Upcoming Investor Conferences
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Reports Third Quarter 2022 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx and Melinta Therapeutics Present Third Annual Innovate4Outcomes(R) Healthcare Design Thinking-Inspired Event
Virtual event takes place December 1, 2022 
From OptimizeRx Corporation
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.